Karapinar Sefa Erdem, Dincer Recep, Atay Tolga, Baykal Yakup Barbaros, Kirdemir Vecihi, Baydar Metin Lutfi
Orthopedics and Traumatology, Suleyman Demirel University, Isparta, TUR.
Cureus. 2024 Jul 11;16(7):e64345. doi: 10.7759/cureus.64345. eCollection 2024 Jul.
Lateral epicondylitis is one of the leading orthopedic problems encountered in daily practice. Treatments are more symptomatic than curative. Percutaneous drilling is a minimally invasive method that provides satisfactory results. The aim of this study was to evaluate patients who had undergone percutaneous drilling for chronic lateral epicondylitis.
The study included 31 patients who underwent surgical percutaneous drilling because of chronic lateral epicondylitis between 2018 and 2021. The patients were evaluated with respect to demographic characteristics, including age, gender, body mass index (BMI), occupation, education level, hobbies, dominant side, and smoking status. The VAS (Visual Analog Scale) pain scores, PRTEE score (Patient-Rated Tennis Elbow Evaluation - a lateral epicondylitis function scale), and Roles-Maudsly score were examined preoperatively and at one and 12 months postoperatively together with grip strength measured with a Jamar hand dynamometer.
Statistically significant improvements were determined in the VAS score during activity from 8.9 preoperatively to 2.06 at 12 months postoperatively (p<0.01), and in the PRTEE score, from 64.12 preoperatively to 20.61 at 12 months postoperatively (p<0.01). The Roles-Maudsly score at 12 months postoperatively was determined to be excellent in 13 (41.9%) patients, and good in 14 (45.2%). Mean grip strength increased from 69.55 before treatment to 90.97 at the end of 12 months postoperatively.
Autobiological treatments are at the forefront of current treatments for tendinopathies. Percutaneous drilling is a closed method and can be considered an ideal method in the treatment of tendinosis caused by inflammation and mesenchymal stem cells (MSCs) contained in hematoma. It is also an advantageous treatment method for patients with aesthetic concerns as it does not leave any scar tissue and has a low risk of complications.
外侧上髁炎是日常临床实践中最常见的骨科问题之一。目前的治疗方法多为对症治疗而非根治性治疗。经皮钻孔是一种微创方法,可取得满意疗效。本研究旨在评估接受经皮钻孔治疗慢性外侧上髁炎的患者。
本研究纳入了2018年至2021年间因慢性外侧上髁炎接受经皮钻孔手术的31例患者。对患者的人口统计学特征进行评估,包括年龄、性别、体重指数(BMI)、职业、教育程度、爱好、优势侧和吸烟状况。术前及术后1个月和12个月,采用视觉模拟评分法(VAS)评估疼痛程度,采用患者自评网球肘评估量表(PRTEE)及Roles-Maudsly评分评估功能状况,同时使用Jamar握力计测量握力。
术后12个月,VAS活动期评分从术前的8.9显著改善至2.06(p<0.01);PRTEE评分从术前的64.12显著改善至20.61(p<0.01)。术后12个月,13例(41.9%)患者的Roles-Maudsly评分为优,14例(45.2%)为良。平均握力从治疗前的69.55增加至术后12个月时的90.97。
自体生物治疗是目前肌腱病治疗的前沿方法。经皮钻孔是一种闭合性方法,可被视为治疗由炎症和血肿中所含间充质干细胞(MSC)引起的肌腱病的理想方法。对于有美观需求的患者,该方法也是一种优势治疗手段,因为它不会留下任何瘢痕组织,且并发症风险低。